Keywords: Par Pharmaceutical, Megace ES, Off-label promotion, Settlement, USA, Justice Department

Par Pharma agrees $45 million settlement over off-label Megace ES promotion

Article | 07 March 2013

Print This

US generic drugmaker Par Pharmaceutical NYSE: PRX) pleaded guilty in federal court yesterday (March 6) and agreed to pay $45 million to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in